EUROFINS Genoma Group Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
100
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
EUROFINS Genoma Group General Information
Description
Provider of genetic and molecular diagnostic services intended for clinical and research purposes. The company's platform offers a wide range of genetic tests across multiple specialist areas, supported by advanced molecular technologies, accredited laboratories, and expert consultation services, enabling healthcare professionals and institutions to access comprehensive diagnostic services for genetic, cytogenetic, and molecular analysis needs throughout Europe.
Contact Information
Website
www.laboratoriogenoma.eu(Operating Subsidiary)
Corporate Office
- Via Castel Giubileo, 11
- 00138 Rome
- Italy
Corporate Office
- Via Castel Giubileo, 11
- 00138 Rome
- Italy
EUROFINS Genoma Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-Jan-2026 | Completed | Generating Revenue | |||
| 1. Merger/Acquisition | 07-Jul-2017 | Completed | Generating Revenue |
EUROFINS Genoma Group Comparisons
Industry
Financing
Details
EUROFINS Genoma Group Competitors (31)
One of EUROFINS Genoma Group’s 31 competitors is Dynacare Healthcare Services, a Formerly PE-Backed company based in Brampton, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dynacare Healthcare Services | Formerly PE-Backed | Brampton, Canada | ||||
| NeoGenomics | Corporation | Fort Myers, FL | ||||
| ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
| Genova Diagnostics | Private Equity-Backed | Asheville, NC | ||||
| American Esoteric Laboratories | Formerly VC-backed | Memphis, TN |
EUROFINS Genoma Group Patents
EUROFINS Genoma Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023343083-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Pending | 12-Sep-2022 | ||
| EP-4587593-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Pending | 12-Sep-2022 | ||
| US-20250327126-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Pending | 12-Sep-2022 | ||
| WO-2024059514-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Inactive | 12-Sep-2022 | ||
| EP-4185716-A1 | Method for in vitro diagnosis of head and neck cancer and related kit | Active | 23-Jul-2020 | C12Q1/6886 |
EUROFINS Genoma Group Signals
EUROFINS Genoma Group FAQs
-
When was EUROFINS Genoma Group founded?
EUROFINS Genoma Group was founded in 1997.
-
Where is EUROFINS Genoma Group headquartered?
EUROFINS Genoma Group is headquartered in Rome, Italy.
-
What is the size of EUROFINS Genoma Group?
EUROFINS Genoma Group has 100 total employees.
-
What industry is EUROFINS Genoma Group in?
EUROFINS Genoma Group’s primary industry is Laboratory Services (Healthcare).
-
Is EUROFINS Genoma Group a private or public company?
EUROFINS Genoma Group is a Private company.
-
What is EUROFINS Genoma Group’s current revenue?
The current revenue for EUROFINS Genoma Group is .
-
Who are EUROFINS Genoma Group’s competitors?
Dynacare Healthcare Services, NeoGenomics, ARUP Laboratories, Genova Diagnostics, and American Esoteric Laboratories are some of the 31 competitors of EUROFINS Genoma Group.
-
When was EUROFINS Genoma Group acquired?
EUROFINS Genoma Group was acquired on 01-Jan-2026.
-
Who acquired EUROFINS Genoma Group?
EUROFINS Genoma Group was acquired by Eurofins Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process